Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by VancouverPigon Nov 21, 2017 8:05am

53 Views

Post# 27001777

RE:RE:RE:RE:Stock options news

Waxie...the only people knocking on my door or giving me a call will be investors thanking me for posting a realistic expectation of what might happen.

I suggest nore investors will be knocking on Howies door or Calling Howie if he does not come through with the paid pumping expectations for NFG1067. I will be one of the knockers and callers. But i expect the phones will go dead and the door will be locked. While they make a new video of course.

As for buying this Shat? Are you joking? I want out in the worst way like a lot of bag holders here.

Signed: VancouverPig who has taken a bath with this SAHAT.

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario